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From some observations made with immune sera, and particularly from the 
evidence provided by tests with occasionally occurring normal and post-trans- 
fusion human sera containing irregular agglutinins (cf. reviews in 1, 2) one can 
conclude that there exist individual properties of human blood other than those 
which are demonstrable by readily available reagents such as A1, A2, B, M, N. 
Doubtless numerous attempts have been made to discover additional agglutin- 
ogens by the familiar technique used for the demonstration of the factors M and 
N  (3), that is, with immune sera prepared by the injection of human blood into 
rabbits, but only few results were obtained (e.g. 4, 5), and these were not fol- 
lowed up because it was difficult to produce the immune sera again.  Other 
ways of approaching the problem were therefore desirable and it was thought 
that new results might be obtained by immunizing with animal instead of hu- 
man blood, considering that the blood of some animals contains antigens related 
to agglutinogens present in individual human bloods, for instance the Forssman 
substance related to A in sheep cells.  A result that favored this plan was the 
observation that certain anti-rhesus  immune sera contain agglutinins specific 
for the human agglutinogen M  (6). 
Pursuing  this  idea,  by immunizing rabbits  with  rhesus  blood an  immune 
serum was obtained with which an agglutinable factor different from A, B, M, 
N, or P was detected (7), and this new factor was designated as Rh to indicate 
that rhesus blood had been used for the production of the serum.  The property 
was  then found to be present in the blood of  about 85 per cent of white indi- 
viduals examined (7,  8). 
Evidence that the property Rh is of clinical importance was obtained when 
one of the writers came into possession of blood samples from patients who had 
shown hemolytic reactions,  one with fatal outcome, after receiving repeated 
* One of the authors (W.) was aided in obtaining the human material by a grant 
from the Committee on Human Heredity of the National Research  Council. 
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transfusions of blood of the proper group (8).  The serum of these patients con- 
tained anti-Rh isoagglutinins while in the blood cells the factor was lacking. 
This showed that the agglutinogen in question,  unlike M  and N, is endowed 
with the capacity to induce the formation of immune isoantibodies in certain 
human beings. 
Another related fact is the appearance of immune isoantibodies in pregnancy. 
Levine and Stetson (9)" had previously reported a  severe accident following a 
transfusion of apparently compatible blood in a  woman after a  stillbirth  and 
offered the explanation that the patient had been immunized by an antigen in 
the  dead fetus,  inherited  from the father.  Furthermore,  in a  review of the 
literature by Wiener and Peters (8)  it was pointed out that apparently every 
recorded instance  in which  a  hemolytic reaction followed a  first transfusion 
with blood of the proper group had occurred with intra- or postpartum patients. 
This supported the above mentioned hypothesis that isoimmunization can re- 
sult from pregnancy.  Further  cases of transfusion reactions attributable  to 
isoimmunization of pregnancy were reported by Levine and Katzin (10).  The 
serum from one of the cases, in which the isoagglutinin was identified, was found 
to give reactions corresponding to those of Rh. 
In a recent paper, Levine, Katzin, and Burnham (11) described a number of cases 
of erythroblastosis foetalis,  stillbirths, and miscarriages, which  appear to be due to 
isoimmunization in pregnancy.  From their results, the authors conclude  that most 
of the mothers developed antibodies against the Rh factor.  Significant  additional 
evidence has been obtained since (23).  Previously the idea of a serological explana- 
tion  of  erythroblastosis  was  advanced  by  Ottenberg  (12) and Darrow  (13). 
The purposes of our own studies were to develop a practical method of test- 
ing for the presence of the Rh factor, and to investigate its heredity. 
EXPERIMENTAL 
The rabbit immune serum described in our preliminary communication gave 
reactions which  were definite,  although  considerably weaker than  those  ob- 
tained with common reagents for blood grouping or M,N tests.  Subsequent 
attempts at producing immune sera in rabbits by injecting rhesus blood gave 
unsatisfactory results even though feeble Rh antibodies were detectable in some 
of the sera.  Such difficulties have also been encountered in work with immune 
sera against other factors (P, O, etc.).  We then turned to the immunization of 
other laboratory animals and obtained sera from guinea pigs which gave reac- 
tions corresponding in specificity to those of the rabbit antibodies. 
For the production of the sera large guinea pigs  were injected intraperitoneally 
with a suspension of washed red cells of rhesus monkeys, each animal receiving a dose 
corresponding  to 1 cc., in later experiments to 2 cc. of whole blood.  The  injection 
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majority of animals were found to show a difference between the two sorts of blood, 
Rh +  and Rh-,  and in a  group of ten animals usually one or more were found that 
yielded sera  suitable  for  practical  diagnosis.  The  manner  of  selecting  the  sera 
is given below. 
While in the case of the immune rabbit sera  the reagent was prepared in the 
customary way by absorbing the diluted serum with  negatively reacting blood, 
it was found with several guinea pig sera that absorption with human  blood 
resulted merely in a non-specific diminution of the agglutinin content, no matter 
whether positive or negative blood was  used.  This led us to test the effect of 
simple dilution, and indeed it was found  that a distinction between positive and 
negative bloods could be made  directly without  absorbing the sera.  (As an 
analogy, mention may be made of rabbit immune anti-A sera which cannot be 
specifically absorbed with A~ cells to produce a  reagent for A1,  absorption with 
A~ blood serving merely to diminish the agglutinin  titer.) 
The method for determining suitable sera consists in making serial dilutions by 
halves and testing with known negative and positive blood.  Those sera which show 
in three (or more) successive dilutions negative reactions with the former and positive 
ones with the latter blood are usable. 
The actual tests can usually be carried out simply by selecting a  dilution of 
the serum, e.g.,  1 to 10, which gives no reactions with negative but definite re- 
actions with positive bloods,  those sera that  contain appreciable amounts  of 
anti-A  or  anti-B  agglutinins  having  been  previously  absorbed  with  small 
quantities of A  and B  blood.  Since the sera are used diluted, inactivation is 
mostly unnecessary.  The blood to be tested should be fresh. 
Another method, alternative to dilution alone, is to absorb the sera diluted, e.g. 
1:4, with a quantity of blood (using A or B cells if indicated) sufficient to remove the 
reaction with Rh-negative blood. 
Two drops (0.1 cc.) of the test fluid are then mixed with one drop of 2 per cent (in 
terms of blood sediment) washed blood suspension, freshly prepared, in a narrow tube 
of 7 mm.  inner diameter and allowed to stand at room temperature.  Readings are 
taken after sedimentation has occurred, usually after 30 minutes to 1 hour, by direct 
inspection of the bases of the tubes, with a  hand lens.  Negatively reacting bloods 
then show a circular deposit with a smooth edge, while positive bloods have a wrinkled 
sediment with a serrated border or show a granular deposit (cf.  Figs. 1 to 6).  From 
these readings, as a rule, the diagnosis can readily be made.  The readings are facili- 
tated by using racks having small holes beneath the bottom of the tubes.  Following 
the reading the tubes are shaken and the sediment examined after it forms again.  A 
further examination is  made  after  2  hours,  again  inspecting  the  sediment.  The 
tubes are then  gently shaken and  the  suspension  is examined microscopically: the 
negative blood samples are mostly perfectly homogeneous;  the positive ones  show 
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the clumping is quite weak in spite of a distinctly positive sediment picture.  Need- 
less to say, positive and negative control bloods should be included in each test. 
As already mentioned,  with  the great majority of specimens the distinction 
between  positive  and  negative  reactions  is  quite  definite  but  the  positive 
reactions  vary in  strength  and  some bloods  offer difficulties  because  of their 
weak  reactions.  However,  after  sufficient  practice,  and  by  repeating  the 
tests  if necessary with fresh blood samples and several sera,  only in some few 
instances were the reactions questionable.  Marked differences in the intensity 
of the  reactions  were  also  observed  in  tests  made  with  human  anti-Rh  sera. 
Whether  the  variations  in  strength  of  agglutination  are  due  to  homo-  and 
Magnification  1:2. 
FIGS.  1 and 2.  Negative reactions; the inner light  disc in Fig.  2 is  due to slight 
convexity in the bottom of the tube. 
FIG. 3.  Faintly positive reaction. 
FIo. 4.  Weak reaction. 
FIGS. 5 and 6.  Typical positive reactions. 
heterozygosity or to the existence  of other differences in the agglutinogen has 
not been determined. 
In order to ascertain  whether  sera from various sources give corresponding 
reactions, comparative tests were made with series of human blood specimens. 
The  immune  rabbit  serum  originally  obtained  (7)  was found to give parallel 
reactions with two human sera (8) from post-transfusion cases in a series of 42 
bloods (29 positive and 13 negative).  Additional tests have now been made to 
compare  the  reactions  of different  guinea  pig  sera  with  each  other  and  with 
human Rh isoagglutinins.  Three of the guinea pig sera were examined with a 
random series of 110 bloods (89 positive, 21 negative) and in no case was a dis- 
crepancy  encountered.  Furthermore,  parallel  tests  were  carried  out  with  a 
guinea  pig  serum,  which  gave  good  differentiation,  and  a  human  serum  1 
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(human serum 3)  obtained from the mother of a  child with erythroblastosis. 
159  bloods  gave corresponding reactions  with  both  sera of which  109  were 
positive and 50 negative.  2  In three cases, there were definite discrepancies; 
one blood reacted distinctly with the human, not with the guinea pig serum, the 
other two were agglutinated by the guinea pig serum, not by human serum 
3, though one of these was agglutinated by two other human sera (Nos. 2, 4). 
Furthermore,  three  specimens  gave doubtful  reactions  with  the  guinea  pig 
serum, one reacting distinctly, one weakly, and one faintly with human serum 3. 
In addition to the blood mentioned above, which gave divergent reactions with 
the two human sera, a  second such blood (not retested)  was found, and in a 
larger series of comparisons made with several human anti-Rh sera, Dr. Philip 
Levine  3 observed that the reactions ran parallel in the great majority of cases, 
but bloods were encountered which were agglutinated differently, e.g.  one by 
one serum, the other by a second serum.  These observations raise the question 
whether there actually exist variants of the property Rh, more different than 
those found for agglutinogens A  (14-16), M  (17), and N  (18), and whether hu- 
man sera may contain more than one kind of anti-Rh agglutinin. 
Of interest in this connection is a serum, obtained from a post-transfusion case (19), 
which differed strikingly from the other human sera in that it gave many more negative 
reactions.  The results are summarized in  Table I  and show  that  in  spite of the 
difference  in the reactions there is a marked correlation,  establishing a  relationship 
between this serum and the other human sera.  If this distribution is compared with 
that to be expected on the assumption that the reactions of this patient's serum would 
be unrelated to Rh, we obtain a value of X  2 equal to approximately 19.9, n being 1 
(cf. Fisher (20)).  The likelihood that this value is due to chance alone is very small. 
To date a  total of 448 white individuals has been examined with guinea pig 
sera, human sera, or both.  4  Among these, there were 379 positive and 69 nega- 
tive reactions, that is, 84.6 per cent Rh+  and 15.4per cent Rh--.  The distribu- 
tion in the sexes, and among the blood groups and ~¢I,N types (cf.  Tables II to 
IV)  did  not  reveal  a  definite  correlation.  Likewise in a series of 133 speci- 
mens tested  for  Rh  and  P  there  was  no definite  correlation  between  these 
two  properties.  The  high  incidence  of  Rh-negative  individuals  in  group 
B  (27.5  4- 4.4 per cent) may still be accidental in view of the small size of the 
series. 
In a  series of 113 negro bloods, only 9 were found to give clearly negative 
reactions, suggesting the possibility of a racial difference in the distribution. 
The large number of negative bloods is due to selection,  in order to increase  the 
significance of the comparison. 
3 Personal communication. 
4 The children  of the family material and the few instances in which the reactions 
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Studies on Heredity.----60  families with 237 children were tested for the pres- 
ence or absence of the factor Rh in the red cells.  The bloods were examined 
not later than 1 day following their collection.  All the bloods were examined 
for the properties A,B, and in most cases for M,N, and the subgroups A1 and 
TABLE I 
Reactions with human serum Wa 
Reactions with typical  human  Rh sera 
Positive  Negative 
Positive ..........................................  31  8 
Negative .........................................  1  11 
TABLE II 
Distribution of the Rh Factor in the Two Sexes 
Number ................ 
Per cent ................ 
Males  Females  Totals 
299  153  [80  ]16  [  379  I  69 
84.9  /  15.1  I  83.3  [  16.7  I  84.6  I  15.4 
TABLE III 
Distribution of the Rk Factor in the Four Blood Groups 
Group O  Group A  Group B  Group AB  Totals 
Rh+  Rh--  Rh___~+ Rh~  Rh--~  Rh~_  R  h__~+  Rh_~_--  ~Rh~-- 
Number ..........  191  29  148  127  29  11  11  I  2  379  169 
/  / 
Percent ..........  ]  86.81 13.2  I  84.6[ 15.4172.3 ]27.5 ] 84.6  J 15.4  I  84.6[  15.4 
TABLE IV 
Distribution of the Rh Factor in the Three M,N Types 
Type N  [  Type MN  Type M  Type MN  Totals 
~h+  Rh--  Rh+  Rh--  Rh+  Rh--  Rh+  ]~h-- 
~'umber ..............  93  20  70  9  [205  I  39  [368  68 
'er cent ..............  82.3  17.7  88.6  11.4  84.0  16.0  84.4  15.6 
A,.  The  tests  for Rh presented  in Tables  V  and VI were made either with 
guinea pig immune  sera,  or with  a  post-transfusion  human  serum,  5 or both. 
While it is realized that the use of two reagents introduces an inaccuracy, this is 
so small in view of the almost complete correspondence shown above between 
these sera that the results cannot be appreciably affected. 
5 With the exception of 4 families,  a single human serum (No. 3) was used. TABLE  V 
List of Family Material 
Family 
Number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
~4t 
15 
16 
17 
18 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
3t 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
4~ 
48 
49 
50 
51 
52 
53t 
54 
55 
56 
57 
58 
59 
6O 
Parents 
Father 
()MNRh- 
Am-NRh+ 
AIMNRh-- 
AIMNRh+ 
AIMRh+ 
OMNRh+ 
BMRh-- 
BMNP,  h-- 
A1MRh+ 
OMNRh+ 
OMNRh+ 
OMNRh+ 
A1MNRh-- 
OMNRh+ 
OMNRh+ 
A1MNRh+ 
AIMNRh+ 
A1NRh-- 
ONRh-- 
AMNRh+ 
OMNRh+ 
AMNRh+ 
A2MRh+ 
OMNRh+ 
A1MNRh-- 
OMRh+ 
OMRh+ 
A.~MNRh+ 
OMNRh+ 
A1MNRh+ 
OMNRh+ 
A1BMNRh-- 
OMNRh+ 
A~BMNRh+ 
A1BIVINRh+ 
BMRh+ 
A~,MNRh+ 
A1MRh+ 
BMRh+ 
A1MNR.h+ 
0NRh+ 
BMRh+ 
0NP.h+ 
AIMNP.h+ 
OMNRh+ 
OMRh+ 
A1BMNRh-- 
OMRh+ 
OMNRh+ 
AIBMRh+ 
BMRh+ 
OMNRh+ 
OMRh+ 
OMNRh-- 
0MNRh  -- 
BNRh-- 
A~MNP,.h+ 
AMNRh-- 
A1MNRh+ 
A1MRh+ 
Mother 
OMRh  -- 
OMNRh+ 
ONRh+ 
AINRh-- 
AIMRh+ 
A1MRh+ 
OMRh-- 
A2MNRh-- 
OMRh+ 
OMNRh+ 
AINRh+ 
OMNR.h+ 
AIMNRh+ 
OM:NRh+ 
AIMNRh+ 
A1NRh+ 
A2MRh+ 
ONl%h+ 
A2MNRh-- 
AMNP.h+ 
A1MNRh+ 
BMRh+ 
BNRh+ 
BMNRh-- 
A1BMNRh+ 
BNRh+ 
A1MNRh+ 
A1MNRh+ 
OMRh+ 
OMNRh+ 
A1NRh+ 
AIlVI2qRh  - 
A2MP.h+ 
OMNRh+ 
A1NRh+ 
OMNRh+ 
BMRh+ 
A1BNRh+ 
OMNRh+ 
AINRh+ 
OMNRh+ 
A2BMNRh+ 
OMNRh+ 
A~.INRh+ 
AIMNRb.+ 
BMNRh+ 
OMNRh+ 
OMNRh+ 
OMRh+ 
OMRh+ 
OMRh+ 
A1MNRh+ 
OMNRh-- 
AIMRh+ 
AMRh-- 
OMNP,  h+ 
A1MNRh+ 
BMRh+ 
ONRh-- 
AIMNRh+ 
Children 
OMNRh--@  OMNRh-- 9  OMNRh-- 9  OMNRh- 9  OMNRh--@  OMNRh-@ 
ONRh+o  ~  A.2MNRh-bo  ~  OMNRh+ 
OMNRh-[.- ~  A1NRh+ 9  OMNRh+ 9  ONP.h-.}-d'  OMNRhq.-c~ 
A1MNR.b.-- 9  A1NRh+ ~  AINRh-o  ~  A1NR.b.+d'  A1NRh-d  ~ 
OMRh+o  ~  OMRh+ 9  OMP,  h+ 9  AIMP,  h+ 9 
OMNRh+ 9  A1MRh-- 9  OMNRh- @  A1MRh+~ 
OMRh-- o  z  BMRh-- o"  BMRh-- 9 
A~dNP,  h-- 9  BNP,  h-- 9 *  A~MNP.h--o  ~* 
OMRh+ 9  OMRh+ 9  A1MRh+o  z 
OMRh+ ~  OMRh+~  OMNR.h+  o  z  OMRh+ 
A2NRh-- 9  A2.MNRh+ 9  AiMNR.h+ ~  AINR.h+ 9  A1MNRh+ 9 
ONRh+o  ~  OMNP,  h+o  ~  OM2qRh+o  ~  OMNRh+ 9 
A1MRh+@  AIMP,  h--o  ~  OMNRh- 
OMRh+ ~  OMRh+ 9  OMNRh+o  ~  OMNRh+ 9  OMRh+o  ~  OMRh+~ 
A1MNRh+ ~  ONRh+ ~  OMNRh+ 9 
OMNRh+ 9  A1MNRh+ 9  OMNRh+o  ~  AINRh+o  ~  AIMNRh+c~  A1MNRh+o  ~ 
A1NRh+ 9 
OMRh+ 9  OMNRh+ 9  OMNRh+o  ~  A1MRh+o  ~  A1MNRh+o  ~  A~MRh+ 
A1MRh+o  z  AIMRh+o  z 
ONRh--cP  A1NRh-- 9  ONRh-- 9  ONRh- 9 
ONRh+o~$  ONRh--o  ~  A2MNRh-o  ~  A2NRh-- 9  A2NRh-- 9  Ag.,NRb.--d' 
OMNRh-- d'  A~IRh-- 9 
AMNRh+ 9  AMNRh+ ~  AMNP.h+o  z  AMRh+cf 
A1NRh+ 9  A1MNRh+ 9 
OMRh+o  z  AMNRh+ 
A2BMNP,  h+ 9  BMNRh+# 
BMNRh+o  ~  ONRh+o  ~  BMNRh+o  ~  BNRh+o" 
BMNRh+o  ~  BMNRh+o  ~  AIBNRh+o  z 
BMNRh+o  z  OMNRh+o  ~  OMNRh+ 9  OMNRh+ 9 
A1MNRh+o  z  A2MNRh+o  ~  A.~MRh+o  ~  AIMNRh+d'  AibiRh+o  ~ 
AIMNRh+ 9  AIMNRh+ 9  AIMNRh+ 
OMNRh+ 9 *-'--OMRh+o  z* 
OMNRh+o  ~  OMNRh+c~ 
AINRh+o  ~  OMNRh+o  ~  A1MNRh- 9  AINRh+ 9  ONRh+d'  OMNRh+ 
A2BMNRh--~  A1MNRh--d,  A1NRh--o  ~  A1MNRh--~  AIMRh-cV  A1MRh--d  ~ 
Ag.BMNRh-- ~  A1BIVINRh-- 9  AIMP,  h-- ~  A1BMRh--~ 
A2MRh+o  z  A2MNRh+ ~,  A2MNP,  h+ 
A2NRh+o  ~  BMRh+ ~  A2MRh+ 9 
BMNRh+ ~  AIMNRh+ 9  A1NRh+o  ~  A1MNRh+o  ~  AIMNRh+ 
OMP,  h+ 9  BM.NRh+ ~  OMNRh+ 9  BMRh+o  ~ 
AgMRh+ 9  BMRh+ 9 
AIBMNRh+o  ~  AIBMNRh+ @ 
BMRh+o  z  BMRh+o"  BMP,  h+ ~  BMP,.h+ @  BMNRh+ 
A1MNRh+o  ~  AINRh+# 
OMNRh+ o  ~  OMNRh+ 
BMRh+ ~  BMNRh+~ 
ONRh+ 9  ONRh+ ~  ONRh+o"  ONP,  b.+~  ONRh+o" 
A1MNRh+ ~  OMP,  h+ 9  A1MRh+ ~  A2MNRh+ 9 
A1MNRh+ ~  OMNRh+ ~  A1MNRh+o  ~  A1NRh+ ~  oMNRh+o"  AIMRh+8' 
OMNRh+o  ~ 
OMRh+ ~  BMNRh+ ~  OMNRh+ 9  OMRh+ cf 
A1NRh+ 9  A1MRh+ 9 
OMRh-- o  ~  OMNRh+ 9  OMRh+ 
OMRh+ ~  OMRh+o" 
BMRh+ ~  BMRh+~ 
OMRh+c~  BMRh+o  ~ 
) OMNRh+o  z  OMNR.h+o  ~  ONP,  h+~  AIMRh+~  A1M.NRh+~  A1MNRh+~ 
OMRh+ 9  OMNRh+ 9  OMRh+d'  OMRh+ ~  OMl'ffR.h+  9 
A2MRh+o  ~  A1MNP,  h-  ~  AIMRh-- 9  A1MR.h+ 9  A~MR.b.+d'  AI.MR.h+¢~ 
OMNRh--~  OMRh--o  ~ 
, BNRh+#  OMNRh+ 9  BMNRh+o"  ONRh+ ~  ONR.h+@ 
A2MRh+o  ~  A2MNRh--o  ~  A~.BMNRh+~  A2NR.h+o  ~  ASM.N'Rh--~ 
ABMRh+o"  AMNRh+o  z  AMNRh+o  z 
ONRh+ ~  OMNRh+d'  A1MNRh+ 
OMMRh+ 9  OMRh+o  ~  OMNRh+o"  A1MNRh+o  ~  A1MRh+ 9 
• Twins.  t Colored family.  ~ Oldest child, and is from s  previous marriage. 
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As is apparent from the results with the families in which both parents are 
Rh-negative,  evidently the property Rh  is inherited  as a  dominant.  In six 
such matings encountered in our series, all 29 children proved to be Rh-nega- 
tire3  (This  number  of  Rh--  X  Rh--  families,  larger  than  would  be 
expected by chance, is in part due to selection of families with a known negative 
parent.) 
In analogy to the other individual human blood properties whose heredity 
has been investigated, one may presume that the factor Rh is transmitted by 
means of a pair of genes, Rh and rh, where the dominant gene Rh determines its 
presence.  Hence, three genotypes would exist, RhRh, Rhrh, and rhrh, the first 
two corresponding to the phenotype Rh+,  the last to Rh--.  By the usual 
simple calculation, one obtains from the distribution of the phenotypes in the 
population  the  frequencies  of  the  two  genes.  In  our  random  series  of 448 
individuals there were 69 or 15.4 per cent Rh-  individuals.  Accordingly, the 
TABLE VI 
Summar of Family Material 
Number of 
families 
Number of children 
Mating 
Rh+  Rh--  Totals 
R.h+  X Rh+  42  151  7  158 
Rh+ X Rh-  12  37  11  48 
Rh-- X Rh--  6  0  31  31 
Totals ..........  60  188  49  237 
frequency of gene rh is n/0.154 or 39.2 per cent, and the frequency of gene Rh 
60.8 per cent.  From these figures the frequencies of the three genotypes are as 
follows: genotype RhRh,  (0.608) 2 or  37.0  per cent;  genotype Rhrh,  2(0.608) 
(0.392)  or 47.6 per cent; and genotype rhrh,  15.4 per cent. 
From the genotype frequencies one can calculate the distribution in the off- 
spring of various matings of the Rh factor to be expected on the hypothesis of 
simple dominance.  In the matings Rh +  X  Rh+, there are three possibilities; 
namely, (1) both parents of genotype RhRh, (2) one parent of genotype RhRh, 
the other Rhrh, and (3) both parents Rhrh.  Only in case (3) can Rh-- children 
occur.  The relative frequency of this mating among Rh+  X  Rh+  families is 
(0'476)2  or 31.6 per cent.  Since one-fourth of all the children of these 
(0.370  +  0.476) 2 
matings should be Rh--, only 7.9 per cent of all the children of Rh+  >( Rh+ 
6 Actually, in one of these families,  in which  blood specimens  were taken from 8 
children,  the oldest boy was Rh-positive, but on investigation it was learned that he 
was the child of a previous marriage.  All individuals in this family were tested with 
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matings should be Rh-negative.  The observed incidence of 7 Rh-- individuals 
among 158 offspring, or 4.4 4-  1.1 per cent, is less than the expected value; to 
decide whether this is accidental or significant, examination of a larger series is 
necessary. 
In the matings Rh+  X  Rh--, two cases exist: (1) genotype RhRh X  rhrh, or 
(2) Rhrh X  rhrh.  Rh-negative children will result only from the second sort of 
mating.  The frequency of such matings among Rh+  X  R_h- families should 
be the same as that of genotype Rhrh among Rh+  individuals, or 56.3 per cent. 
Hence half of 56.3, or 28.15 per cent of the children from all the Rh+  X  Rh-- 
matings should be Rh-negative.  The figure observed was 11  among 48 chil- 
dren,  or 22.9 ±  4.0 per cent, which does not differ significantly from the pre- 
dicted value. 
The usefulness of the blood property Rh for forensic exclusion of paternity is 
small, on account of the low incidence of matings R_h--  X  Rh--  (0.15  X  0.15, 
or only 2.25 per cent), these being the only ones which permit a  decision. ~  For 
individual identification in medicolegal cases, determination of the Rh factor 
doubles  the  number of classifications,  but  only fresh blood,  not  dried  blood 
stains,  can be tested. 
Perusal of the data listed in Table V indicates that  the property Rh is not a 
sex-linked dominant factor.  This follows firstly from the equal distribution of 
the factor in the two sexes (cf.  Table II), and secondly from the analysis of 
families in which the father is positive and the mother negative (families 4, 24, 
53, and 59 of Table V), where on the usual hypothesis only the offspring of one 
sex, most probably the daughters, would exhibit the character. 
Significant  data relating to the question  of the linkage relation of property Rh arid 
the agglutinogens  A and B are provided by family 6, and also by family 54 if one makes 
use of the subgroups A1 and A2.  In family 6, the mother is heterozygous for both A 
and R.h, the father, who belongs to group O, only for Rh.  In this family only R.h- 
negative children  yield information as to linkage (cf. 21);  that one of the two Rh- 
negative children  belongs to group A, the other to group O, is evidence against close 
linkage.  Similarly, the mother in family 54 is evidently of genotype AIA2Rhrh, the 
father of genotype OOrhrh.  In a mating of this kind children of types A~Rh +  and 
A1Rh-  belong to one category (either linked or crossover), those of types AIRh+ 
and A~Rh- to the other.  As there are 5 children  of one sort and 1 of the other, this 
family does not furnish evidence for close linkage. 
Information as to the linkage relations of property Rh and agglutinogens M,N is 
By chance such a  case was encountered among a  few forensic  examinations in 
which  tests  for Rh  were  made.  The  test  showed  the  following:  putative father, 
BMRh-;  mother,  A~BMRh-;  child,  AIBMNRh+.  Consequently,  a  paternity 
exclusion could be made from three independent results; namely, the subgroups, the 
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provided only by families 4, 6, and 13.  In family 4, three of the children belong to one 
class, two to the other class; in family 6 two children can be used, and one of these 
belongs to each class; finally, in family 13 only two of the children can be used, and 
again one belongs to each class.  These results point strongly to independent assort- 
ment, though the possibility of a loose linkage cannot be excluded. 
COMMENT 
From the clinical facts mentioned in the introduction, it is apparent that a 
test by which Rh+  and Rh-  individuals can be distinguished is of practical 
importance for the selection of blood donors in certain instances.  This occasion 
arises in cases of repeated transfusion to Rh-  patients, in whom the injection 
of Rh+ blood is sometimes harmful.  The same indication obtains even at the 
very first transfusion in pregnancy when the woman is of type Rh-.  For 
these reasons, where blood donor organizations exist, it will be helpful to exam- 
ine the donors in order to have available a list of Rh-  individuals.  The fact 
that occasionally doubtful reactions may be encountered is of no consequence 
for the selection of Rh-  donors, as such individuals can be excluded.  To per- 
form compatibility tests will be important, even when the donor's blood has 
been tested with anti-Rh sera, and should be conducted also at body tempera- 
ture (22). 
The test that has been described is not as perfect as one would desire, since 
the reactions are not strong, but with proper attention reliable results can as a 
rule be obtained.  A favorable circumstance is the ease with which the reagent 
was prepared.  The tests can also be made with the occasionally occurring hu- 
man sera containing Rh agglutinins, but such sera are not always at hand, and 
unless a sufficient number of individuals previously tested for the factor are avail- 
able, it may not be possible to establish the identity of a  given irregular iso- 
agglutinin with anti-Rh.  Therefore, it is of value to possess in the guinea pig 
antisera a reagent which can be obtained at will.  Moreover, indications were 
found of differences in the reactions of various human sera reacting on Rh+ 
blood, while the guinea pig sera appeared to be uniform and most likely can be 
used as a standard.  If the agglutinable property proves to be a species charac- 
ter in  the monkey, this  could account for the  uniformity of the antibodies 
induced by rhesus blood, but it has not yet been determined  whether  there 
are individual differences in rhesus blood with regard to the factor. 
As  regards  the nature  of the  reactions described,  it might be questioned 
whether they actually indicate a special agglutinable property or merely differ- 
ing degrees of agglutinability, in view of the failure to separate Rh agglutinins 
from  the guinea pig  sera  by absorption with  negative bloods.  The second 
assumption can be eliminated, however, because a separation was possible with 
rabbit immune sera, and the Rh agglutinins in human sera do not react at all 
on  negative  bloods  and  can  be  specifically  absorbed. KARL  LANDSTEINER  AND  ALEXANDER  S. Vv-IENER  31~ 
The investigation of families leads one to conclude that  the factor is in- 
herited as a simple Mendelian dominant, which is not sex-linked.  If further 
studies should prove the factor to be linked to neither A,B nor M,N, as one 
might surmise from our own scanty data, the property Rh may serve to mark a 
new pair of chromosomes for linkage studies. 
The authors are indebted to Mr. Jack Black and Miss E. H. Tetschner for their 
assistance. 
SUMMARY 
Studies are reported on an individual  agglutinogen  (Rh)  in human blood 
which has been found to be of clinical importance because occasionally it gives 
rise to the formation of immune isoantibodies in man, a peculiarity which leads 
to untoward transfusion reactions. 
A method for the determination of the presence or absence of the new blood 
factor is described, which can be used for typing patients and prospective blood 
donors. 
Examination of families showed that the agglutinogen is inherited as a simple 
Mendelian dominant.  The distribution oi the factor Rh among white individ- 
uals  and negroes may indicate  racial  differences.  The property is probably 
genetically independent of the blood groups and the factors M  and N. 
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